Roma Parikh

Suggest Changes
Learn More
PURPOSE CEREBEL compared the incidence of CNS metastases as first site of relapse in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer receiving(More)
e19027 Background: Lapatinib is an oral, reversible small-molecule inhibitor of epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2). EGFR overexpression is(More)
TPS105 Background: HER2 gene product is overexpressed in ~20% of breast cancer and is associated with an aggressive phenotype and poor prognosis. Finding suitable patients with HER2+ MBC who adhere(More)
  • 1